NSCMNatural Supplement for Body Composition Improvement in Physically Active Individuals
This study examines if the Novel Natural Supplement (NNS) can enhance muscle mass in physically active people. Over 8 weeks, muscle mass will be measured using bioelectrical impedance analysis to see how the supplement affects it.
Novel Natural Supplement (NNS)
+ Placebo
Treatment Study
Summary
Study start date: June 17, 2024
Actual date on which the first participant was enrolled.This clinical trial explores the effectiveness of a new natural supplement in improving body composition and metabolic health for endurance-trained individuals. The supplement includes a mix of plant-based proteins, fibers, and antioxidants aimed at increasing lean muscle, reducing body fat, and supporting heart and lung health. The ingredients in this supplement are whey protein, pea protein, oats, sweet potato, flaxseed, chia seeds, spinach powder, cardamom, green tea extract, beetroot powder, and stevia. This study is important because it seeks to scientifically validate whether such a multi-ingredient supplement can offer tangible health benefits for active people looking to enhance their physical fitness and metabolic functions. Participants in the study are randomly divided into two groups: one receiving the natural supplement and the other a placebo, with neither the participants nor the researchers knowing who is in which group. The supplement or placebo is taken daily for eight weeks. Researchers measure body composition using a technique that analyzes body fat and lean mass, alongside checking oxygen levels, heart rate, and various blood markers related to metabolism. These assessments help determine the supplement's impact on muscle growth, weight loss, and overall metabolic health. By evaluating these outcomes, the study aims to provide a clearer picture of the potential benefits of natural, protein-rich supplements for physically active individuals.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.65 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 45 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
ExperimentalGroup II
PlaceboStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location